+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Somatostatin Analogs Market - Global Forecast 2025-2032 - Product Thumbnail Image

Somatostatin Analogs Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 188 Pages
  • Global
From
Immuno Oncology Assays Market - Global Forecast 2025-2032 - Product Thumbnail Image

Immuno Oncology Assays Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 198 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
From
From
CDK4/6 Inhibitors Market - Global Forecast 2025-2030 - Product Thumbnail Image

CDK4/6 Inhibitors Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 193 Pages
  • Global
From
Oral CDK4/6 Inhibitors Market - Global Forecast 2025-2030 - Product Thumbnail Image

Oral CDK4/6 Inhibitors Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 199 Pages
  • Global
From
From
From
From
From
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more